BHC Pharmaceutical: Government Tender Performance Analysis

BHC Pharmaceutical Private Limited has begun establishing a presence in India's government tender ecosystem, participating in 1 tenders during FY2024-25. This initial analysis examines their early tender participation, technical qualification rate, and emerging procurement strategy, focusing on the period from April 2024 to March 2025.

Superior Tender Success Rate of 100.0%

BHC Pharmaceutical demonstrates exceptional government tender performance with an impressive win ratio of 100.0% in FY2024-25. Out of 1 tenders, they have secured 1 L1 positions (lowest bid winners), establishing them as a highly competitive government contractor. The company has also achieved 0 L2 and 0 L3 positions, further highlighting their consistent ability to offer competitive pricing. The single win secured a contract value of ₹3,050.

Financial Health Assessment

TenderAI's financial health score for BHC Pharmaceutical is 57.5 out of 100, categorized as 'Satisfactory'. The score is derived from components including win rate (100), contract value (0.0), bid efficiency (100.0), growth (50.0), and consistency (0). While the win rate and bid efficiency are strong, there's room for improvement in contract value and consistency, indicating potential for growth in securing larger contracts.

Market Positioning in the Tender Landscape

BHC Pharmaceutical is positioning itself as a strong contender in the government procurement space, particularly within the pharmaceutical sector. Their high qualification rate and successful L1 bid demonstrate a clear understanding of tender requirements and competitive pricing strategies. The company's initial focus is on the Health & Family Welfare Department Gujarat.